Skip to contents
Peter Henry Schur
Senior Physician, Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
Rheumatology, Immunology
75 Francis Street
Boston, MA 02115


Edit Profile


Research Narrative:

Investigative Interests: Autoantibodies to TNF, CRP, CCP


Publications (Pulled from Harvard Catalyst Profiles):

1. Ford JA, Liu X, Marshall AA, Zaccardelli A, Prado MG, Wiyarand C, Lu B, Karlson EW, Schur PH, Deane KD, Sparks JA. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested CCP-Positive Patients Without RA. Arthritis Care Res (Hoboken). 2018 Dec 20.

2. Simmons DP, Herskovits AZ, Battinelli EM, Schur PH, Lemire SJ, Dorfman DM. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity. Clin Chem Lab Med. 2018 Jul 26; 56(8):1289-1296.

3. Shi CR, Schur PH, Nambudiri VE. From Paris to Vienna-The Varied Names and Descriptions of Cutaneous Lupus Erythematosus in the 19th Century. JAMA Dermatol. 2017 10 01; 153(10):998.

4. Engelhart S, Glynn RJ, Schur PH. Disease associations with isolated elevations of each of the four IgG subclasses. Semin Arthritis Rheum. 2017 10; 47(2):276-280.

5. Lazaridou A, Kim J, Cahalan CM, Loggia ML, Franceschelli O, Berna C, Schur P, Napadow V, Edwards RR. Effects of Cognitive-Behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia. Clin J Pain. 2017 03; 33(3):215-221.

6. Schur PH. Laboratory testing for the diagnosis, evaluation, and management of systemic lupus erythematosus: Still more questions for the next generations: A Tribute and Thanks and in Memory of my mentor: Henry G. Kunkel. Clin Immunol. 2016 Nov; 172:117-121.

7. Costenbader KH, Schur PH. We need better classification and terminology for "people at high risk of or in the process of developing lupus". Arthritis Care Res (Hoboken). 2015 May; 67(5):593-6.

8. Rao DA, Wei K, Merola JF, O'Brien WR, Takvorian SU, Dellaripa PF, Schur PH. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing. J Rheumatol. 2015 May; 42(5):847-52.

9. Al Daabil M, Massarotti EM, Fine A, Tsao H, Ho P, Schur PH, Bermas BL, Costenbader KH. Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up. Int J Clin Pract. 2014 Dec; 68(12):1508-13.

10. Merola JF, Bermas B, Lu B, Karlson EW, Massarotti E, Schur PH, Costenbader KH. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014 Jul; 23(8):778-84.